Acinetobacter baumannii has emerged in the last decades as a major cause of healthcare-associated infections and nosocomial outbreaks. Multidrug-resistant (MDR) A. baumannii is a rapidly emerging ...

Tigecycline has been studied against MDR A. baumannii infections and demonstrated good microbiological and clinical activity. In the next few years extensive use could affect its activity ...